Clinical Trial Update: The Effects of Mogroside Sweetener on Viral Load in TreatmenT Naive Genotype 1 (GT 1) Subjects CHC [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial assessing the effect of mogroside sweetener on hepatitis C viral load in treatment-naive genotype 1 patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Mogroside Sweetener (mogroside)

Snippet

Sponsor: Brooke Army Medical Center | Conditions: Hepatitis C | Phase 2 | Status: COMPLETED